Acadian Asset Management
LEGN icon

Acadian Asset Management’s Legend Biotech LEGN Stock Holding History

Acadian Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$824K Sell
28,596
-1,498,740
-98% -$40.4M ﹤0.01% 1315
2026
Q1 		$27.6M Buy
1,527,336
+945,182
+162% +$18M 0.04% 330
2025
Q4 		$12.6M Buy
+582,154
New +$16.7M 0.02% 432
2023
Q3 		– Sell
-248
Closed -$17K – 1755
2023
Q2 		$17K Buy
+248
New +$16.2K ﹤0.01% 1657

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Acadian Asset Management's LEGN Position: Q2 2026 in Review

Acadian Asset Management reduced its Legend Biotech (LEGN) stake by 98% in Q2 2026, selling an estimated $40.4M and leaving 28,596 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Acadian Asset Management first reported a position in LEGN in Q2 2023 and has held it in 4 quarters since. The position peaked at $27.6M in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Acadian Asset Management held 28,596 shares of Legend Biotech worth $824K as of Q2 2026.
  • Acadian Asset Management sold 1,498,740 Legend Biotech shares in Q2 2026, an estimated $40.4M.
  • Legend Biotech made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1315 holding.
  • Acadian Asset Management first reported a position in Legend Biotech in Q2 2023 and has held it in 4 quarters since.
  • Acadian Asset Management's Legend Biotech position peaked at $27.6M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.